| Primary |
| Immunosuppression |
14.7% |
| Juvenile Arthritis |
12.8% |
| Immunosuppressant Drug Therapy |
7.3% |
| Sjogren's Syndrome |
7.3% |
| Drug Use For Unknown Indication |
6.4% |
| Systemic Lupus Erythematosus |
6.4% |
| Multiple Sclerosis |
5.5% |
| Transplant Rejection |
5.5% |
| Osteoporosis Prophylaxis |
4.6% |
| Dermatomyositis |
3.7% |
| Immune Enhancement Therapy |
3.7% |
| Peripheral T-cell Lymphoma Unspecified Recurrent |
3.7% |
| Bronchitis |
2.8% |
| Exposure To Toxic Agent |
2.8% |
| Inflammation |
2.8% |
| Pneumocystis Jiroveci Pneumonia |
2.8% |
| Anaemia Haemolytic Autoimmune |
1.8% |
| Arthralgia |
1.8% |
| Arthritis |
1.8% |
| Atrial Fibrillation |
1.8% |
|
| Venous Thrombosis |
8.6% |
| Epidural Lipomatosis |
5.7% |
| Liver Injury |
5.7% |
| Nervousness |
5.7% |
| Radicular Pain |
5.7% |
| Resuscitation |
5.7% |
| Rhonchi |
5.7% |
| Swollen Tongue |
5.7% |
| Thrombocytopenia |
5.7% |
| Urticaria |
5.7% |
| Vision Blurred |
5.7% |
| Visual Impairment |
5.7% |
| Vomiting |
5.7% |
| Weight Increased |
5.7% |
| Abdominal Distension |
2.9% |
| Abnormal Behaviour |
2.9% |
| Abscess Intestinal |
2.9% |
| Acute Myocardial Infarction |
2.9% |
| Anxiety |
2.9% |
| Blood Glucose Increased |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
17.6% |
| Immunosuppression |
10.8% |
| Renal Transplant |
8.8% |
| Graft Versus Host Disease |
8.6% |
| Non-hodgkin's Lymphoma |
7.5% |
| Prophylaxis Against Graft Versus Host Disease |
6.3% |
| Systemic Lupus Erythematosus |
5.3% |
| Prophylaxis |
4.6% |
| Therapeutic Procedure |
4.3% |
| Nephrotic Syndrome |
4.1% |
| Rheumatoid Arthritis |
4.1% |
| Premedication |
2.7% |
| Prophylaxis Against Transplant Rejection |
2.5% |
| Dermatomyositis |
2.2% |
| Pain |
2.2% |
| Temporal Arteritis |
2.1% |
| Infection Prophylaxis |
1.8% |
| Acute Graft Versus Host Disease |
1.7% |
| Anaemia Haemolytic Autoimmune |
1.5% |
| Asthma |
1.4% |
|
| Sepsis |
20.0% |
| Focal Segmental Glomerulosclerosis |
8.6% |
| Renal Impairment |
7.9% |
| Staphylococcal Infection |
6.4% |
| Pyrexia |
5.7% |
| Respiratory Failure |
5.7% |
| Hepatic Neoplasm Malignant Recurrent |
4.3% |
| Pneumocystis Jiroveci Pneumonia |
4.3% |
| Tumour Lysis Syndrome |
4.3% |
| Colitis |
3.6% |
| Urinary Tract Infection |
3.6% |
| Adenocarcinoma |
2.9% |
| Death |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| Necrotising Retinitis |
2.9% |
| Progressive Multifocal Leukoencephalopathy |
2.9% |
| Prostate Cancer |
2.9% |
| Renal Failure Acute |
2.9% |
| Tendonitis |
2.9% |
| Vasculitis |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
51.3% |
| Rheumatoid Arthritis |
8.1% |
| Renal Transplant |
7.6% |
| Asthma |
4.2% |
| Hypertension |
3.0% |
| Multiple Sclerosis |
2.7% |
| B-cell Lymphoma |
2.5% |
| Immunosuppression |
2.2% |
| Depression |
2.0% |
| Non-small Cell Lung Cancer |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.9% |
| Premedication |
1.9% |
| Colitis Ulcerative |
1.6% |
| Hypersensitivity |
1.5% |
| Prophylaxis |
1.5% |
| Immunosuppressant Drug Therapy |
1.3% |
| Arthritis |
1.3% |
| Psoriatic Arthropathy |
1.3% |
| Sedation |
1.2% |
| Prophylaxis Against Graft Versus Host Disease |
1.0% |
|
| Vomiting |
11.3% |
| Ocular Hyperaemia |
6.8% |
| Sepsis |
6.8% |
| Type 2 Diabetes Mellitus |
6.8% |
| White Blood Cell Count Decreased |
6.8% |
| Transplant Rejection |
6.0% |
| Weight Increased |
6.0% |
| Respiratory Failure |
4.5% |
| Rhabdomyolysis |
4.5% |
| Bronchospasm |
3.8% |
| Cytolytic Hepatitis |
3.8% |
| Pancreatitis Chronic |
3.8% |
| Paraesthesia |
3.8% |
| Pyrexia |
3.8% |
| Rash |
3.8% |
| Renal Failure |
3.8% |
| Upper Respiratory Tract Infection |
3.8% |
| Urticaria |
3.8% |
| Vasculitis |
3.8% |
| Drug Exposure During Pregnancy |
3.0% |
|
